TCA
FLGT icon

Trifecta Capital Advisors’s Fulgent Genetics FLGT Stock Holding History

Trifecta Capital Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-475
Closed -$9.32K – 415
2024
Q2 		$9.32K Hold
475
– – ﹤0.01% 220
2024
Q1 		$10.3K Hold
475
– – ﹤0.01% 201
2023
Q4 		$13.7K Hold
475
– – ﹤0.01% 194
2023
Q3 		$12.7K Hold
475
– – ﹤0.01% 201
2023
Q2 		$17.6K Hold
475
– – 0.01% 188
2023
Q1 		$14.8K Hold
475
– – 0.01% 198
2022
Q4 		$14.1K Buy
+475
New +$17K 0.01% 179

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trifecta Capital Advisors's FLGT Position: Q3 2024 in Review

Trifecta Capital Advisors sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 475 shares — an estimated $9.32K sold.

Trifecta Capital Advisors first reported a position in FLGT in Q4 2022 and held it in 7 quarters. The position peaked at $17.6K in Q2 2023. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Trifecta Capital Advisors reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Trifecta Capital Advisors sold 475 Fulgent Genetics shares in Q3 2024, an estimated $9.32K.
  • Trifecta Capital Advisors first reported a position in Fulgent Genetics in Q4 2022 and held it in 7 quarters.
  • Trifecta Capital Advisors's Fulgent Genetics position peaked at $17.6K in Q2 2023.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Trifecta Capital Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.